Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease
出版年份 2011 全文链接
标题
Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease
作者
关键词
-
出版物
CIRCULATION
Volume 123, Issue 20, Pages 2263-2273
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2011-05-24
DOI
10.1161/circulationaha.110.981738
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase activator, BAY 60–2770, are not dependent on endogenous nitric oxide or reduced heme
- (2011) Edward A. Pankey et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Dependence of Golgi apparatus integrity on nitric oxide in vascular cells: implications in pulmonary arterial hypertension
- (2011) Jason E. Lee et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase stimulator, BAY 41-8543, are modulated by nitric oxide
- (2010) Adeleke M. Badejo et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Pre-conditioning with the soluble guanylate cyclase activator Cinaciguat reduces ischaemia–reperfusion injury after cardiopulmonary bypass
- (2010) Tamás Radovits et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- BAY 41-2272 inhibits the development of chronic hypoxic pulmonary hypertension in rats
- (2010) Lise Bech Thorsen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study
- (2010) H. A. Ghofrani et al. EUROPEAN RESPIRATORY JOURNAL
- Emerging drugs for pulmonary hypertension
- (2010) Reda E Girgis EXPERT OPINION ON EMERGING DRUGS
- Structure of Cinaciguat (BAY 58–2667) Bound toNostocH-NOX Domain Reveals Insights into Heme-mimetic Activation of the Soluble Guanylyl Cyclase
- (2010) Faye Martin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models
- (2010) Yuliya Sharkovska et al. JOURNAL OF HYPERTENSION
- CINACIGUAT, A SOLUBLE GUANYLATE CYCLASE ACTIVATOR, UNLOADS THE HEART IN ACUTE DECOMPENSATED HEART FAILURE
- (2010) Erland Erdmann et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pulmonary hypertension with left-sided heart disease
- (2010) Marco Guazzi et al. Nature Reviews Cardiology
- Guanylyl cyclase activator ataciguat improves vascular function and reduces platelet activation in heart failure
- (2010) Andreas Schäfer et al. PHARMACOLOGICAL RESEARCH
- Soluble Guanylate Cyclase Agonists Inhibit Expression and Procoagulant Activity of Tissue Factor
- (2009) Mikhail A. Sovershaev et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation
- (2009) LS Hoffmann et al. BRITISH JOURNAL OF PHARMACOLOGY
- Stimulation of cGMP signalling protects coronary endothelium against reperfusion-induced intercellular gap formation
- (2009) S. A. Kasseckert et al. CARDIOVASCULAR RESEARCH
- Discovery of Riociguat (BAY 63-2521): A Potent, Oral Stimulator of Soluble Guanylate Cyclase for the Treatment of Pulmonary Hypertension
- (2009) Joachim Mittendorf et al. ChemMedChem
- Pharmacological Activation of Soluble Guanylate Cyclase Protects the Heart Against Ischemic Injury
- (2009) Sevil Korkmaz et al. CIRCULATION
- ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
- (2009) et al. CIRCULATION
- Cinaciguat (BAY 58–2667) Improves Cardiopulmonary Hemodynamics in Patients With Acute Decompensated Heart Failure
- (2009) Harald Lapp et al. CIRCULATION
- BAY 58-2667, a nitric oxide-independent guanylyl cyclase activator, pharmacologically post-conditions rabbit and rat hearts
- (2009) T. Krieg et al. EUROPEAN HEART JOURNAL
- First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension
- (2009) F. Grimminger et al. EUROPEAN RESPIRATORY JOURNAL
- Discovery of the nitric oxide signaling pathway and targets for drug development
- (2009) Nathan et al. Frontiers in Bioscience-Landmark
- Role of guanylate cyclase modulators in decompensated heart failure
- (2009) Veselin Mitrovic et al. HEART FAILURE REVIEWS
- Pressure-independent effects of pharmacological stimulation of soluble guanylate cyclase on fibrosis in pressure-overloaded rat heart
- (2009) Hiroyuki Masuyama et al. HYPERTENSION RESEARCH
- Pulmonary hypertension in chronic heart failure
- (2009) D. Bonderman et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Diagnosis, Assessment, and Treatment of Non-Pulmonary Arterial Hypertension Pulmonary Hypertension
- (2009) Marius M. Hoeper et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
- (2009) Sharon Ann Hunt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial Hypertension
- (2009) Robyn J. Barst et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cellular and Molecular Basis of Pulmonary Arterial Hypertension
- (2009) Nicholas W. Morrell et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics
- (2009) Emily J. Tsai et al. PHARMACOLOGY & THERAPEUTICS
- From arginine methylation to ADMA: A novel mechanism with therapeutic potential in chronic lung diseases
- (2009) Dariusz Zakrzewicz et al. BMC Pulmonary Medicine
- Acute hemodynamic response to single oral doses of BAY 60-4552, a soluble guanylate cyclase stimulator, in patients with biventricular heart failure
- (2009) Veselin Mitrovic et al. BMC Pharmacology & Toxicology
- Cardioprotective effects in aged spontaneously hypertensive rats due to chronic stimulation/activation of sGC without hypotension
- (2009) Emma S Jones et al. BMC Pharmacology & Toxicology
- Novel soluble guanylyl cyclase stimulator BAY 41-2272 attenuates ischemia-reperfusion-induced lung injury
- (2008) Bakytbek Egemnazarov et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Probing the presence of the ligand-binding haem in cellular nitric oxide receptors
- (2008) B Roy et al. BRITISH JOURNAL OF PHARMACOLOGY
- Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension
- (2008) R. T. Schermuly et al. EUROPEAN RESPIRATORY JOURNAL
- Role of oxidative stress and nitric oxide in atherothrombosis
- (2008) Edith Lubos Frontiers in Bioscience-Landmark
- Increased adhesive properties of neutrophils in sickle cell disease may be reversed by pharmacological nitric oxide donation
- (2008) A. A. Canalli et al. HAEMATOLOGICA
- Effects of 5′-Phosphodiesterase Four-Week Long Inhibition With Sildenafil in Patients With Chronic Heart Failure: A Double-Blind, Placebo-Controlled Clinical Trial
- (2008) Alice Behling et al. JOURNAL OF CARDIAC FAILURE
- Single-Dose Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of the Soluble Guanylate Cyclase Stimulator BAY 63-2521: An Ascending-Dose Study in Healthy Male Volunteers
- (2008) Reiner Frey et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Sustained Soluble Guanylate Cyclase Stimulation Offsets Nitric-Oxide Synthase Inhibition to Restore Acute Cardiac Modulation by Sildenafil
- (2008) T. Nagayama et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Dose-dependent beneficial hemodynamic effects of BAY 41-2272 in a canine model of acute pulmonary thromboembolism
- (2007) Stefany B.A. Cau et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now